Wednesday’s Highlights at Noon: LendingClub (LC), Groupon (GRPN), Goodrich Petroleum (GDP), Helmerich & Payne (HP), Cormedix (CRMD)

So far Wednesday, November 18, NASDAQ is up 0.81% and the S&P is down -1.11%. Here are this morning’s most active stocks: LendingClub (LCResearch Report), Groupon (GRPNResearch Report), Goodrich Petroleum (GDPResearch Report), Helmerich & Payne (HPResearch Report) and Cormedix (CRMDResearch Report).

LendingClub is up 16.4% in midday trading to $6.67. Shares opened today at $5.73. The company has a 52-week low of $4.32 and a 52-week high of $14.08. On the Street’s front, the average 12-month analyst price target for the stock is $8.17, marking a 42.58% potential upside from current levels. In a report issued on November 9, Maxim Group analyst Michael Diana maintained a Hold rating on LC.

Groupon is up 10.97% in midday trading to $28.32. Shares opened today at $25.52. The company has a 52-week low of $9.60 and a 52-week high of $63.20. On the Street’s front, the average 12-month analyst price target for the stock is $23.25, marking a -8.89% potential downside from current levels. In a report issued on November 9, Credit Suisse analyst Stephen Ju maintained a Hold rating on GRPN, with a price target of $31.00, which implies an upside of 21% from current levels. Separately, on the same day, Barclays’ Deepak Mathivanan maintained a Sell rating on the stock and has a price target of $18.00.

Goodrich Petroleum is down -10.21% in midday trading to $11.61. Shares opened today at $12.93. The company has a 52-week low of $2.40 and a 52-week high of $13.30. On the Street’s front, the average 12-month analyst price target for the stock is $13.50, marking a 4.41% potential upside from current levels. In a report issued on November 6, Northland Securities analyst Jeff Grampp assigned a Buy rating on GDP, with a price target of $14.00, which represents a potential upside of 8% from where the stock is currently trading.

See today’s analyst top recommended stocks >>

Helmerich & Payne is up 8.42% in midday trading to $20.72. Shares opened today at $19.11. The company has a 52-week low of $12.40 and a 52-week high of $47.33. On the Street’s front, the average 12-month analyst price target for the stock is $16.38, marking a -14.29% potential downside from current levels. In a report issued on October 16, RBC analyst Kurt Hallead maintained a Buy rating on HP, with a price target of $20.00, which represents a slight upside potential from current levels. Separately, on October 14, Goldman Sachs’ Angie Sedita maintained a Hold rating on the stock and has a price target of $20.00. In the last 30 days, insiders have sold $168.9K worth of HP shares.

Cormedix is down -8.14% in midday trading to $6.43. Shares opened today at $7.00. The company has a 52-week low of $2.16 and a 52-week high of $7.97. On the Street’s front, the average 12-month analyst price target for the stock is $16.00, marking a 128.57% potential upside from current levels. In a report issued on November 16, H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on CRMD, with a price target of $10.00, which represents a potential upside of 43% from where the stock is currently trading. Over the last 3 months, the insider sentiment on Cormedix has been positive based on 16 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.